3 results match your criteria: "Centre de Recherche du CHU St-Justine[Affiliation]"

Microbiome perturbations can have long-term effects on health. The dynamics of the gut microbiome and virome in women living with HIV (WLHIV) and their newborn infants is poorly understood. Here, we performed metagenomic sequencing analyses on longitudinal stool samples including 23 mothers (13 WLHIV, 10 HIV-negative) and 12 infants that experienced SARS-CoV-2 infection with mild disease, as well as 40 mothers (18 WLHIV, 22 HIV-negative) and 60 infants that remained SARS-CoV-2 seronegative throughout the study follow-up.

View Article and Find Full Text PDF

HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants.

PLoS One

January 2023

Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Centre de Recherche du CHU St-Justine, Montréal, Québec, Canada.

Background: HIV may increase SARS-CoV-2 infection risk and COVID-19 severity generally, but data are limited about its impact on postpartum women and their infants. As such, we characterized SARS-CoV-2 infection among mother-infant pairs in Nairobi, Kenya.

Methods: We conducted a nested study of 62 HIV-uninfected and 64 healthy women living with HIV, as well as their HIV-exposed uninfected (N = 61) and HIV-unexposed (N = 64) infants, participating in a prospective cohort.

View Article and Find Full Text PDF
Article Synopsis
  • A variety of ELISAs have been created to detect SARS-CoV-2 antibodies since the pandemic began, highlighting the need to evaluate their reliability across different populations.
  • This study compares the Platelia Total Ab Assay (Bio-Rad) with the Mount Sinai spike IgG ELISA using plasma samples from a mother-infant group in Nairobi, finding a high agreement (92.7%) and strong correlation (R = 0.973) between the two assays.
  • The results suggest that both assays provide similar seroprevalence estimates for the Kenyan population and are effective regardless of HIV exposure status, supporting the Platelia assay as a viable option for seroprevalence research in Kenya.
View Article and Find Full Text PDF